Health Trials

Relapsed or Refractory T Cell Lymphoma

1

Review clinical trials related to Relapsed or Refractory T Cell Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

This study will investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 in patients with relapsed or refractory T cell Lymphoma

Participants needed: 217
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Ono Pharmaceutical Co., Ltd.Updated: Feb 13, 2026Locations: 20
Eligibility criteria

Patients aged ≥ 18 years at time of screening [+9]

Patients with central nervous system (CNS) involvement [+10]

Read more